Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Flibanserin improves libido in women with breast cancer
    Meeting Abstract

    Goldfarb, S.; Carter, J.; Arkema, A.; Abdo, N.; Carpio, A.; Chang, C.; Vahdat, L.
    Journal of Sexual Medicine (2022)

    Fulltext@MSK | Save
  • Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple negative breast cancer: A feasibility study
    Meeting Abstract

    Walsh, E. M.; Gucalp, A.; Patil, S.; Edelweiss, M.; Ross, D. S.; Razavi, P.; Modi, S.; Iyengar, N. M.; Sanford, R.; Troso-Sandoval, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Adjuvant palbociclib for ER+ breast cancer (PALLAS Trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13): A preplanned analysis of the stage IIA cohort
    Meeting Abstract

    DeMichele, A.; Dueck, A. C.; Hlauschek, D.; Martin, M.; Burstein, H. J.; Pfeiler, G.; Zdenkowski, N.; Wolff, A. C.; Balic, M.; Miller, K.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • The Society for Integrative Oncology: Two decades of global leadership in evidence-based integrative health care
    Editorial

    Rao, S.; Paller, C. J.; Lopez, A. M.; MacLeod, J.; Bao, T.; Carlson, L. E.
    Journal of Integrative and Complementary Medicine (2022)

    Fulltext@MSK | Save
  • A randomized controlled trial of routine financial toxicity screening via electronic patient-reported outcomes (AFT-39)
    Meeting Abstract

    Blinder, V. S.; Deal, A. M.; Ginos, B. F.; Jansen, J.; Dueck, A. C.; Mazza, G. L.; Henson, S.; Carr, P. M.; Rogak, L. J.; Weiss, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Presence of BRCA mutations and a pre-chemotherapy AMH level of < 2NG/ML strongly predict risk of amenorrhea in women with breast cancer
    Meeting Abstract

    Oktay, K. H.; Turan, V.; Bedoschi, G.; Goldfarb, S.; Bang, H.
    Fertility and Sterility (2022)

    Fulltext@MSK | Save
  • Event-free survival in patients with early HER2-positive breast cancer with a pathological complete response after HER2-targeted therapy: A pooled analysis
    Journal Article

    Swain, S. M.; Macharia, H.; Cortes, J.; Dang, C.; Gianni, L.; Hurvitz, S. A.; Jackisch, C.; Schneeweiss, A.; Slamon, D.; Valagussa, P.; more...
    Cancers (2022)

    Fulltext@MSK | Save
  • Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants
    Journal Article

    Liu, Y. L.; Maio, A.; Kemel, Y.; Salo-Mullen, E. E.; Sheehan, M.; Tejada, P. R.; Trottier, M.; Arnold, A. G.; Fleischut, M. H.; Latham, A.; more...
    Cancer (2022)

    Fulltext@MSK | Save
  • Associations between circulating proteins and risk of breast cancer by intrinsic subtypes: A Mendelian randomisation analysis
    Journal Article

    Shu, X.; Zhou, Q.; Sun, X.; Flesaker, M.; Guo, X.; Long, J.; Robson, M. E.; Shu, X. O.; Zheng, W.; Bernstein, J. L.
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • An interactive mobile application versus an educational booklet to promote job retention in women undergoing adjuvant chemotherapy for breast cancer: A randomized controlled trial
    Journal Article

    Blinder, V. S.; Patil, S.; Finik, J.; Makower, D.; Muppidi, M.; Lichtenthal, W. G.; Parker, P. A.; Claros, M.; Suarez, J.; Narang, B.; more...
    Trials (2022)

    Fulltext@MSK | Save